A Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a Phase 1, non-randomized, sequential-cohort, dose escalation, open-label study
designed to evaluate the safety and tolerability of RadProtect® in healthy volunteers. This
study is to be conducted at two clinical centers and in conformity with Good Clinical
Practice (GCP).